Consensus report of the 2nd International Forum for Liver MRI.

Akihiro Tanimoto, Jeong Min Lee, Takamichi Murakami, Alexander Huppertz, Masatoshi Kudo, Luigi Grazioli

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Discussion at the 2nd Forum for Liver MRI: The International Primovist User Meeting on the use of the hepatocyte-specific contrast agent gadolinium-ethoxybenzyl-diethylene triamine penta-acetic acid (Gd-EOB-DTPA) is reported. Changes to the currently recommended Gd-EOB-DTPA imaging protocol were identified that can reduce the overall examination time. The potential benefits of 3-T MR imaging using Gd-EOB-DTPA have yet to be fully explored. Data show that Gd-EOB-DTPA-enhanced MRI allows identification of liver lesions and provides a differential diagnosis of hepatocellular nodules in the noncirrhotic and cirrhotic liver, based on vascularity, during the dynamic arterial, portal-venous and late phases, and during the hepatocytespecific phase. Current European, American and Japanese guidelines for the diagnosis of hepatocellular carcinoma need to take into account the recent rapid advances in liver imaging. Based on published clinical trials and the experience of the attendees in the use of Gd-EOB-DTPA in liver imaging, a new simplified, non-invasive diagnostic algorithm was proposed that would be applicable to both Eastern and Western clinical practice in the evaluation of hepatocarcinogenesis and hepatocellular carcinoma. Preliminary clinical experience suggests that Gd-EOB-DTPA may also provide an innovative and cost-effective one-stop approach for staging rectal cancer using wholebody imaging.

Original languageEnglish
JournalEuropean Radiology
Volume19 Suppl 5
Publication statusPublished - 2009 Oct

Fingerprint

Rubiaceae
Gadolinium
Acetic Acid
Liver
Hepatocellular Carcinoma
Rectal Neoplasms
Contrast Media
diethylenetriamine
Hepatocytes
Differential Diagnosis
Clinical Trials
Guidelines
Costs and Cost Analysis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Tanimoto, A., Lee, J. M., Murakami, T., Huppertz, A., Kudo, M., & Grazioli, L. (2009). Consensus report of the 2nd International Forum for Liver MRI. European Radiology, 19 Suppl 5.

Consensus report of the 2nd International Forum for Liver MRI. / Tanimoto, Akihiro; Lee, Jeong Min; Murakami, Takamichi; Huppertz, Alexander; Kudo, Masatoshi; Grazioli, Luigi.

In: European Radiology, Vol. 19 Suppl 5, 10.2009.

Research output: Contribution to journalArticle

Tanimoto, A, Lee, JM, Murakami, T, Huppertz, A, Kudo, M & Grazioli, L 2009, 'Consensus report of the 2nd International Forum for Liver MRI.', European Radiology, vol. 19 Suppl 5.
Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L. Consensus report of the 2nd International Forum for Liver MRI. European Radiology. 2009 Oct;19 Suppl 5.
Tanimoto, Akihiro ; Lee, Jeong Min ; Murakami, Takamichi ; Huppertz, Alexander ; Kudo, Masatoshi ; Grazioli, Luigi. / Consensus report of the 2nd International Forum for Liver MRI. In: European Radiology. 2009 ; Vol. 19 Suppl 5.
@article{1457dfeed5fb461aa4a4e770b10a081c,
title = "Consensus report of the 2nd International Forum for Liver MRI.",
abstract = "Discussion at the 2nd Forum for Liver MRI: The International Primovist User Meeting on the use of the hepatocyte-specific contrast agent gadolinium-ethoxybenzyl-diethylene triamine penta-acetic acid (Gd-EOB-DTPA) is reported. Changes to the currently recommended Gd-EOB-DTPA imaging protocol were identified that can reduce the overall examination time. The potential benefits of 3-T MR imaging using Gd-EOB-DTPA have yet to be fully explored. Data show that Gd-EOB-DTPA-enhanced MRI allows identification of liver lesions and provides a differential diagnosis of hepatocellular nodules in the noncirrhotic and cirrhotic liver, based on vascularity, during the dynamic arterial, portal-venous and late phases, and during the hepatocytespecific phase. Current European, American and Japanese guidelines for the diagnosis of hepatocellular carcinoma need to take into account the recent rapid advances in liver imaging. Based on published clinical trials and the experience of the attendees in the use of Gd-EOB-DTPA in liver imaging, a new simplified, non-invasive diagnostic algorithm was proposed that would be applicable to both Eastern and Western clinical practice in the evaluation of hepatocarcinogenesis and hepatocellular carcinoma. Preliminary clinical experience suggests that Gd-EOB-DTPA may also provide an innovative and cost-effective one-stop approach for staging rectal cancer using wholebody imaging.",
author = "Akihiro Tanimoto and Lee, {Jeong Min} and Takamichi Murakami and Alexander Huppertz and Masatoshi Kudo and Luigi Grazioli",
year = "2009",
month = "10",
language = "English",
volume = "19 Suppl 5",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Consensus report of the 2nd International Forum for Liver MRI.

AU - Tanimoto, Akihiro

AU - Lee, Jeong Min

AU - Murakami, Takamichi

AU - Huppertz, Alexander

AU - Kudo, Masatoshi

AU - Grazioli, Luigi

PY - 2009/10

Y1 - 2009/10

N2 - Discussion at the 2nd Forum for Liver MRI: The International Primovist User Meeting on the use of the hepatocyte-specific contrast agent gadolinium-ethoxybenzyl-diethylene triamine penta-acetic acid (Gd-EOB-DTPA) is reported. Changes to the currently recommended Gd-EOB-DTPA imaging protocol were identified that can reduce the overall examination time. The potential benefits of 3-T MR imaging using Gd-EOB-DTPA have yet to be fully explored. Data show that Gd-EOB-DTPA-enhanced MRI allows identification of liver lesions and provides a differential diagnosis of hepatocellular nodules in the noncirrhotic and cirrhotic liver, based on vascularity, during the dynamic arterial, portal-venous and late phases, and during the hepatocytespecific phase. Current European, American and Japanese guidelines for the diagnosis of hepatocellular carcinoma need to take into account the recent rapid advances in liver imaging. Based on published clinical trials and the experience of the attendees in the use of Gd-EOB-DTPA in liver imaging, a new simplified, non-invasive diagnostic algorithm was proposed that would be applicable to both Eastern and Western clinical practice in the evaluation of hepatocarcinogenesis and hepatocellular carcinoma. Preliminary clinical experience suggests that Gd-EOB-DTPA may also provide an innovative and cost-effective one-stop approach for staging rectal cancer using wholebody imaging.

AB - Discussion at the 2nd Forum for Liver MRI: The International Primovist User Meeting on the use of the hepatocyte-specific contrast agent gadolinium-ethoxybenzyl-diethylene triamine penta-acetic acid (Gd-EOB-DTPA) is reported. Changes to the currently recommended Gd-EOB-DTPA imaging protocol were identified that can reduce the overall examination time. The potential benefits of 3-T MR imaging using Gd-EOB-DTPA have yet to be fully explored. Data show that Gd-EOB-DTPA-enhanced MRI allows identification of liver lesions and provides a differential diagnosis of hepatocellular nodules in the noncirrhotic and cirrhotic liver, based on vascularity, during the dynamic arterial, portal-venous and late phases, and during the hepatocytespecific phase. Current European, American and Japanese guidelines for the diagnosis of hepatocellular carcinoma need to take into account the recent rapid advances in liver imaging. Based on published clinical trials and the experience of the attendees in the use of Gd-EOB-DTPA in liver imaging, a new simplified, non-invasive diagnostic algorithm was proposed that would be applicable to both Eastern and Western clinical practice in the evaluation of hepatocarcinogenesis and hepatocellular carcinoma. Preliminary clinical experience suggests that Gd-EOB-DTPA may also provide an innovative and cost-effective one-stop approach for staging rectal cancer using wholebody imaging.

UR - http://www.scopus.com/inward/record.url?scp=73449096833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449096833&partnerID=8YFLogxK

M3 - Article

C2 - 19851766

AN - SCOPUS:73449096833

VL - 19 Suppl 5

JO - European Radiology

JF - European Radiology

SN - 0938-7994

ER -